These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34255554)

  • 21. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatically Derived Yolk Sac Tumor of the Ovary in a Young Woman.
    Hodgson A; Ghorab Z; Parra-Herran C
    Int J Gynecol Pathol; 2021 May; 40(3):296-300. PubMed ID: 32209818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive urothelial carcinoma with squamous differentiation and associated high-risk human papilloma virus infection: Clinical, cytologic, and histologic features of a rare entity.
    Baban F; Auen T; Eschbacher KL; Swanson AA; Hartley CP
    Ann Diagn Pathol; 2023 Apr; 63():152103. PubMed ID: 36640642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report.
    Kamei M; Shinohara T; Kasahara K; Kuno T; Naruse K; Watanabe H
    J Med Case Rep; 2015 Sep; 9():199. PubMed ID: 26358638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
    Kryvenko ON; Epstein JI
    J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
    Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
    Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience in the use of confocal laser endomicroscopy for the diagnosis of bladder papillary tumors].
    Shoaydarov MA; Martov AG; Andronov AS; Dutov SV; Pominalnaya VM
    Urologiia; 2023 May; (2):99-106. PubMed ID: 37401712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC14A1 (UT-B) gene rearrangement in urothelial carcinoma of the bladder: a case report.
    Guo Z; Niu X; Fu G; Yang B; Chen G; Sun S
    Diagn Pathol; 2020 Jul; 15(1):94. PubMed ID: 32703295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac.
    Nogales FF; Quiñonez E; López-Marín L; Dulcey I; Preda O
    Histopathology; 2014 Jul; 65(1):51-9. PubMed ID: 24444105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma.
    Montoya-Cerrillo D; Briski LM; Jorda M; Kryvenko ON
    Int J Surg Pathol; 2022 May; 30(3):260-264. PubMed ID: 34665053
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.
    Agarwal H; Babu S; Rana C; Kumar M; Singhai A; Shankhwar SN; Singh V; Sinha RJ
    Indian J Pathol Microbiol; 2019; 62(2):244-250. PubMed ID: 30971548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall.
    Mirsadraei L; Hodkoff A; Jones K; Shabaik A; Kader AK; Saenz CC; Montironi R; Tacha DE; Fadare O; Hansel DE
    Arch Pathol Lab Med; 2018 Feb; 142(2):168-177. PubMed ID: 28795841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder.
    Paner GP; Cox RM; Richards K; Akki A; Gokden N; Lopez-Beltran A; Krausz T; McKenney JK; Steinberg GD
    Am J Surg Pathol; 2014 Sep; 38(9):1251-9. PubMed ID: 25133708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
    Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
    Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
    Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
    Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.